Advanced Solutions for Contract Development and Manufacturing Organizations

At Medical Packaging Inc., LLC (MPI), we specialize in providing advanced packaging and labeling solutions tailored to the unique needs of Contract Development and Manufacturing Organizations (CDMOs) in the pharmaceutical industry. Our extensive experience and innovative technology empower CDMOs to meet regulatory requirements and deliver high-quality solutions for drug development and manufacturing services across the United States, North America, and beyond.

MPI’s flexible and customizable systems support early-stage development through commercial manufacturing, offering unparalleled technical expertise for small molecule drugs, gene therapy, and liquid formulations. With a dedicated team and a commitment to quality assurance, MPI is the trusted partner to CDMOs for delivering innovative solutions that align with global market demands.

Enhance Manufacturing Efficiency with MPI’s Expertise

In the fast-paced CDMO environment, efficient and reliable manufacturing processes are critical. MPI’s advanced technologies and packaging solutions streamline operations, reduce errors, and ensure regulatory compliance. From formulation development to analytical services, our products optimize every stage of the manufacturing process, enabling pharma and biotech companies to focus on their core competencies.

Ensure Regulatory Compliance and Quality Assurance

Navigating regulatory requirements is a key challenge for CDMOs. MPI provides world-class expertise in regulatory compliance, analytical methods, and quality assurance to support CDMOs in delivering safe and effective pharmaceutical products. Our packaging, labeling, and barcode solutions meet stringent standards, ensuring accuracy and traceability throughout the supply chain.

Specific Products and Services for CDMOs

FDA-Compliant Liquid Packaging Solutions

MPI’s liquid cup unit dose packaging systems are FDA-compliant and designed to meet the complex needs of CDMOs managing liquid formulations. These systems ensure secure, precise, and high-quality packaging for clinical trials and commercial manufacturing.

Auto-Wrap® Syringe Labeling System

Our Auto-Wrap® system automates syringe labeling, enabling CDMOs to improve workflow efficiency while maintaining accuracy. With the ability to label up to 20 syringes per minute, this solution supports the high-demand environments of drug development and manufacturing.

Pharmacy Accessory Label Printers (PALP)

MPI’s PALP system offers fast and accurate labeling solutions for vials, syringes, and ampoules. Equipped with the Pak-EDGE® UD Barcode Labeling Software, this system ensures compliance and supports efficient operations for CDMOs.

Pak-EDGE Barcode Labeling Software for Regulatory Support

MPI’s solutions extend beyond packaging, offering robust support for analytical development and regulatory compliance. Our tools and systems ensure that CDMOs can meet industry standards while maintaining a focus on drug safety and efficacy.

Commitment Across Other Markets

MPI proudly serves various sectors within the pharmaceutical industry, leveraging our expertise to support diverse needs:

• Specialty Pharma: Customized solutions for small-scale, high-precision manufacturing.
• Pharmaceutical Repackagers: Flexible systems for managing large-scale medication distribution.
• Acute Care & Hospitals: Streamlined solutions to reduce medication errors and improve patient safety.

Enhancing Our Support: DMF

Medical Packaging Inc., LLC (MPI) has proudly achieved a milestone with the original submission and acceptance of a Type III Drug Master File. This specific DMF number relates to packaging materials, underscoring MPI’s commitment to excellence in pharmaceutical packaging. We disclosed every packaging material, component, intended usage, as well as manufacturer information to demonstrate our product quality.

This accomplishment is not just a testament to our advanced technology and production capacity but also aligns with our goal of being a fully integrated provider in the pharmaceutical packaging industry. By obtaining a DMF, MPI can directly ensure that all regulatory requirements are seamlessly met, enhancing speed-to-market capability and reinforcing our status as a trusted partner in the pharmaceutical and medical devices sector.

Supporting Our CDMO Customers with DMF

Having our own DMF means MPI can provide more direct and efficient support to our customers. This eliminates reliance on third-party vendors for critical regulatory and technical documentation and additional information, reducing potential delays in FDA filings. By streamlining the process, we ensure that our customers can focus more on their core activities like clinical trials, drug development, and marketing authorization without the added regulatory burden.

For a specialty pharmaceutical company, manufacturers, or CDMO, MPI’s DMF signifies our ability to meet the stringent requirements for FDA-compliant liquid cup packaging, essential for lower-volume, high-value medicinal products.